ADMA Q1 2018 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+53.8% YoY

Gross Profit

-$8M-202.9% margin

Operating Income

-$17M-409.0% margin

Net Income

-$18M-440.9% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

-66.3%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$514,784

Balance Sheet

Total Assets

$91M

Total Liabilities

$68M

Stockholders' Equity

$23M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+53.8%
Gross Profit	-$8M	$1M	-909.9%
Operating Income	-$17M	-$6M	-178.5%
Net Income	-$18M	-$7M	-172.6%